I think it is fair to say that we all now know where the highest grade Lithium is at the Paradox basin.
On page 13 that small yellow square pegged area where 500ppm was recorded is near the centre of the roundish pink shaded area.
All the high grades are near any of the pink shaded areas ,unfortunately Anson only has a small square of the best ground at this stage ,but enough to be a company maker.
The Anson ground surrounds the best ground apart from the small pegged yellow square where a re entry will be made to confirm that 500ppm Li or more is in the area ,once this ground has been granted and approved for re entry.
The point I'm getting at is that the company can now be comfortable that they are looking in the right area and that any new ground acquired in the area of the cross cutting sections within this pink shaded area would result in a huge spike in the share price.
Anyone selling now very well may miss out on a big spike if management manage to negotiate and acquire some more of that high grade area.
- Forums
- ASX - By Stock
- ASN
- Ann: Anson Investor Presentation - April 2018
Ann: Anson Investor Presentation - April 2018, page-19
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASN (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.7¢ |
Change
0.002(2.67%) |
Mkt cap ! $104.2M |
Open | High | Low | Value | Volume |
7.5¢ | 7.9¢ | 7.5¢ | $295.0K | 3.838M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 102030 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 488402 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 102030 | 0.077 |
3 | 325000 | 0.076 |
5 | 325619 | 0.075 |
7 | 795203 | 0.074 |
9 | 829602 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 488402 | 8 |
0.080 | 915284 | 5 |
0.081 | 1226780 | 5 |
0.082 | 351614 | 2 |
0.083 | 500000 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
ASN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online